Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianfei Tu

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Oncotarget|August 18, 2016
MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinomaJiansong Ji, Min Xu, Jianfei Tu, et al.
Clinical Immunology (Orlando, Fla.)|October 14, 2021
Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic deathBufu Tang, Wangting Xu, Yajie Wang, et al.
Combinatorial Chemistry & High Throughput Screening|May 31, 2019
Recognition of Lung Adenocarcinoma-specific Gene Pairs Based on Genetic Algorithm and Establishment of a Deep Learning Prediction ModelZhongwei Zhao, Xiaoxi Fan, Lili Yang, et al.
International Journal of Biological Macromolecules|January 7, 2023
Monodisperse CaCO<sub>3</sub>-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatmentMinjiang Chen, Xiaoju Guo, Lin Shen, et al.
Heliyon|September 4, 2024
Dual-energy computed tomography for predicting cervical lymph node metastasis in laryngeal squamous cell carcinomaJianfei Tu, Guihan Lin, Weiyue Chen, et al.
Biological Procedures Online|May 19, 2023
TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCCBufu Tang, Yajie Wang, Jinyu Zhu, et al.
European Journal of Medical Research|February 12, 2026
Efficacy and safety of bronchial artery chemoembolization combined with chemotherapy and immune checkpoint inhibitors for advanced lung squamous cell carcinomaLiyun Zheng, Dengke Zhang, Yeyu Zhang, et al.
Frontiers in Molecular Biosciences|September 17, 2021
A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency AblationShiji Fang, Linqiang Lai, Jinyu Zhu, et al.
Oncotarget|March 19, 2016
SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han populationJiansong Ji, Min Xu, Zhongwei Zhao, et al.
Cell Death & Disease|September 22, 2018
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistanceMin Xu, Shiji Fang, Jingjing Song, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Oncotarget|August 18, 2016
MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinomaJiansong Ji, Min Xu, Jianfei Tu, et al.
Clinical Immunology (Orlando, Fla.)|October 14, 2021
Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic deathBufu Tang, Wangting Xu, Yajie Wang, et al.
Combinatorial Chemistry & High Throughput Screening|May 31, 2019
Recognition of Lung Adenocarcinoma-specific Gene Pairs Based on Genetic Algorithm and Establishment of a Deep Learning Prediction ModelZhongwei Zhao, Xiaoxi Fan, Lili Yang, et al.
International Journal of Biological Macromolecules|January 7, 2023
Monodisperse CaCO<sub>3</sub>-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatmentMinjiang Chen, Xiaoju Guo, Lin Shen, et al.
Heliyon|September 4, 2024
Dual-energy computed tomography for predicting cervical lymph node metastasis in laryngeal squamous cell carcinomaJianfei Tu, Guihan Lin, Weiyue Chen, et al.
Biological Procedures Online|May 19, 2023
TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCCBufu Tang, Yajie Wang, Jinyu Zhu, et al.
European Journal of Medical Research|February 12, 2026
Efficacy and safety of bronchial artery chemoembolization combined with chemotherapy and immune checkpoint inhibitors for advanced lung squamous cell carcinomaLiyun Zheng, Dengke Zhang, Yeyu Zhang, et al.
Frontiers in Molecular Biosciences|September 17, 2021
A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency AblationShiji Fang, Linqiang Lai, Jinyu Zhu, et al.
Oncotarget|March 19, 2016
SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han populationJiansong Ji, Min Xu, Zhongwei Zhao, et al.
Cell Death & Disease|September 22, 2018
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistanceMin Xu, Shiji Fang, Jingjing Song, et al.
Pageof 11